Cyclobarbital

Cyclobarbital, also known as cyclobarbitol or cyclobarbitone, is a barbiturate derivative.[1] It was available in Russia as a fixed-dose combination with diazepam (100 mg cyclobarbital + 10 mg diazepam; brand name Reladorm) for the treatment of insomnia but was discontinued in 2019.

Cyclobarbital
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration		Oral (tablets)
ATC code
Legal status
Legal status
  • CA: Schedule IV
  • DE: Anlage II (Authorized trade only, not prescriptible)
  • UK: Class B
  • UN: Psychotropic Schedule III
Pharmacokinetic data
MetabolismHepatic
ExcretionRenal
Identifiers
IUPAC name
  • 5-(1-cyclohexenyl)-5-ethyl-1,3-diazinane-2,4,6-trione
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.000.127
Chemical and physical data
FormulaC12H16N2O3
Molar mass236.271 g·mol−1
3D model (JSmol)
SMILES
  • O=C1NC(=O)NC(=O)C1(/C2=C/CCCC2)CC
InChI
  • InChI=1S/C12H16N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h6H,2-5,7H2,1H3,(H2,13,14,15,16,17) Y
  • Key:WTYGAUXICFETTC-UHFFFAOYSA-N Y
 NY (what is this?)  (verify)

References
  1. Breimer DD, Winten MA (March 1976). "Pharmacokinetics and relative bioavailability of cyclobarbital calcium in man after oral administration". European Journal of Clinical Pharmacology. 09 (5–6): 443–50. doi:10.1007/bf00606563. PMID 989475. S2CID 20271169.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.